BARK Valuation
Is BARK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BARK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BARK ($1.68) is trading below our estimate of fair value ($7.17)
Significantly Below Fair Value: BARK is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BARK?
Key metric: As BARK is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is BARK's PS Ratio? | |
|---|---|
| PS Ratio | 0.6x |
| Sales | US$488.88m |
| Market Cap | US$281.81m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | -9.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BARK's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.4x | ||
BNED Barnes & Noble Education | 0.2x | n/a | US$255.5m |
BRLT Brilliant Earth Group | 0.05x | 1.1% | US$158.7m |
ELA Envela | 1x | 11.2% | US$169.5m |
LESL Leslie's | 0.4x | 3.4% | US$510.4m |
BARK BARK | 0.6x | 10.4% | US$281.8m |
Price-To-Sales vs Peers: BARK is expensive based on its Price-To-Sales Ratio (0.6x) compared to the peer average (0.4x).
Price to Sales Ratio vs Industry
How does BARK's PS Ratio compare vs other companies in the US Specialty Retail Industry?
Price-To-Sales vs Industry: BARK is expensive based on its Price-To-Sales Ratio (0.6x) compared to the US Specialty Retail industry average (0.4x).
Price to Sales Ratio vs Fair Ratio
What is BARK's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.6x |
| Fair PS Ratio | 0.7x |
Price-To-Sales vs Fair Ratio: BARK is good value based on its Price-To-Sales Ratio (0.6x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$1.68 | US$2.23 +32.4% | 20.2% | US$3.00 | US$1.90 | n/a | 4 |
| Nov ’25 | US$1.42 | US$2.23 +56.7% | 20.2% | US$3.00 | US$1.90 | n/a | 4 |
| Oct ’25 | US$1.59 | US$2.23 +39.9% | 20.2% | US$3.00 | US$1.90 | n/a | 4 |
| Sep ’25 | US$1.67 | US$2.23 +33.2% | 20.2% | US$3.00 | US$1.90 | n/a | 4 |
| Aug ’25 | US$1.44 | US$2.23 +54.5% | 20.2% | US$3.00 | US$1.90 | n/a | 4 |
| Jul ’25 | US$1.74 | US$2.23 +27.9% | 20.2% | US$3.00 | US$1.90 | n/a | 4 |
| Jun ’25 | US$1.30 | US$1.95 +50.0% | 32.5% | US$3.00 | US$1.40 | n/a | 4 |
| May ’25 | US$1.15 | US$1.95 +69.6% | 32.5% | US$3.00 | US$1.40 | n/a | 4 |
| Apr ’25 | US$1.23 | US$1.95 +58.5% | 32.5% | US$3.00 | US$1.40 | n/a | 4 |
| Mar ’25 | US$1.25 | US$1.86 +48.8% | 35.5% | US$3.00 | US$1.40 | n/a | 4 |
| Feb ’25 | US$0.97 | US$1.77 +82.0% | 40.8% | US$3.00 | US$1.20 | n/a | 4 |
| Jan ’25 | US$0.81 | US$1.76 +118.5% | 41.1% | US$3.00 | US$1.20 | n/a | 4 |
| Dec ’24 | US$0.81 | US$1.90 +135.4% | 41.4% | US$3.00 | US$1.20 | n/a | 3 |
| Nov ’24 | US$1.05 | US$3.00 +185.7% | 36.0% | US$4.00 | US$1.50 | US$1.42 | 3 |
| Oct ’24 | US$1.20 | US$3.00 +150.0% | 36.0% | US$4.00 | US$1.50 | US$1.59 | 3 |
| Sep ’24 | US$1.60 | US$3.00 +87.5% | 36.0% | US$4.00 | US$1.50 | US$1.67 | 3 |
| Aug ’24 | US$1.46 | US$3.00 +105.5% | 36.0% | US$4.00 | US$1.50 | US$1.44 | 3 |
| Jul ’24 | US$1.33 | US$3.00 +125.6% | 36.0% | US$4.00 | US$1.50 | US$1.74 | 3 |
| Jun ’24 | US$1.06 | US$4.30 +305.7% | 40.1% | US$7.00 | US$2.20 | US$1.30 | 4 |
| May ’24 | US$1.08 | US$4.30 +298.1% | 40.1% | US$7.00 | US$2.20 | US$1.15 | 4 |
| Apr ’24 | US$1.45 | US$4.30 +196.6% | 40.1% | US$7.00 | US$2.20 | US$1.23 | 4 |
| Mar ’24 | US$1.34 | US$4.30 +220.9% | 40.1% | US$7.00 | US$2.20 | US$1.25 | 4 |
| Feb ’24 | US$2.11 | US$5.13 +142.9% | 38.0% | US$8.00 | US$2.50 | US$0.97 | 4 |
| Jan ’24 | US$1.49 | US$5.00 +235.6% | 42.4% | US$8.00 | US$2.00 | US$0.81 | 4 |
| Dec ’23 | US$1.70 | US$6.50 +282.4% | 23.1% | US$8.00 | US$5.00 | US$0.81 | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
Best Buy
US$18.6b
Engages in the retail of technology products in the United States, Canada, and international.
BBY
US$86.51
7D
-5.5%
1Y
27.2%
Frasers Group
UK£3.2b
Frasers Group Plc, together with its subsidiaries, retails sports and leisure clothing, footwear, homeware, furniture, sports equipment and bicycles, accessories, and apparel through department stores, shops, and online in the United Kingdom, Europe, the United States, Asia, Oceania, and internationally.
SDIP.F
UK£9.72
7D
0%
1Y
n/a
Pets at Home Group
UK£1.3b
Engages in the specialist omnichannel retailing of pet food, pet related products, and pet accessories in the United Kingdom.
PAHG.F
UK£3.99
7D
0%
1Y
-5.0%